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Background: Since breastfeeding is universally recognised as the ideal way to feed infants, it is understandable, and
at times inevitable, that breastfeeding mothers will want, or be required, to take medication. To meet the
information demands of breastfeeding mothers and healthcare professionals, a UK charity, The Breastfeeding
Network, established a free telephone helpline to answer queries on medicines in breastmilk. This study reports on
the enquiries received by the Drugs in Breastmilk Helpline and user opinion of the service.
Methods: All enquirers to the Helpline between December 2010 and January 2011 were asked if they could be
contacted in 2 to 4 weeks to provide more information on their experience of using the service. A combination of
telephone semi-structured interviews and email surveys were used depending on whether the enquiry originated
via telephone or email.
Results: Information was gained from 101 participants; 77 women and 24 healthcare professionals. Women
reported high levels of service satisfaction (94%, n = 72/77) and healthcare professionals found the information
provided useful (92%, n = 22/24). Women used the service for reassurance or because they had received conflicting
information or distrusted healthcare professional advice. Healthcare professionals often could not answer questions
or took a cautious approach to recommendation (i.e. advised avoidance of medicines whilst breastfeeding); this was
often at odds to advice given by staff from the Helpline. Healthcare professionals did not routinely access resources
to answer questions, but when they did, showed a lack of confidence in data interpretation.
Conclusions: The Breastfeeding Networks’ Drugs in Breastmilk Helpline provides an important service to
breastfeeding women and healthcare staff to make informed decisions on medicine taking whilst breastfeeding.
Healthcare professional uncertainty and incorrect advice given to breastfeeding women suggests that healthcare
professional education needs improving and that greater use of specialist services should be encouraged.
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It is widely acknowledged that breastfeeding provides
the ideal nutrition for infants, with authorities world-
wide recommending exclusive breastfeeding for the first
six months for children living in developed countries [1,2].
Despite such endorsements, studies have shown that
physician knowledge on breastfeeding is far from ideal
[3-8], as they receive relatively little formal training on
breastfeeding [5], and often fail to follow evidence-based
medicine (EBM) guidelines [9]. However, it can be diffi-
cult for physicians to keep up-to-date with the high* Correspondence: paul.rutter@wlv.ac.uk
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distribution, and reproduction in any mediumvolume of constantly changing, sometimes conflicting,
information. It has been suggested that a physician needs
to read 17 articles each day to keep up with current med-
ical literature, yet they have limited time to assess the in-
formation they receive [10]. Additionally, studies have
shown that access to EBM resources is variable [11-16],
and even when resources are available, the ability of physi-
cians to locate relevant information and assess its validity
appears limited [11,12,17].
It is therefore unsurprising that physicians may turn to
specialist information services for help. Such services in-
clude, UKMi (a UK National Health Service [NHS] funded
medicines information service that has specialist centres
taking medicine calls on pregnancy and breastfeeding) [18]
and the Motherisk Program (a Canadian-based teratogentral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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at healthcare professionals, who report high levels of satis-
faction with the information provided [20,21]. Equivalent
information services for consumers are limited, but the
Breastfeeding Network (BfN) (a UK-based charity estab-
lished in 1997) aims to be an independent source of sup-
port and information for breastfeeding women and others,
including healthcare professionals [22]. One of the BfN
services is the provision of ‘Supporterline’; a service where
information and support is provided to mothers who are
breastfeeding that is complementary to that of health visi-
tors (a health visitor is a UK qualified nurse whose role
promotes health in the whole community, particularly
involved with families who have children under five),
midwives and other healthcare professionals. In 2006
the Supporterline took over 20,000 calls, many specific-
ally related to medicine use. Consequently, in 2007 a na-
tional 0800 (free) telephone service for medicine-related
enquiries was established, The Drugs in Breastmilk Help-
line, which has seen year-on-year increases in enquiry num-
bers (e.g. 576 in 2007, which had risen to 2215 in 2010). To
cope with this increased demand, the service now operates
seven days a week and when not manned takes calls via an
answer machine. The majority of enquiries are answered by
a pharmacist, with support from a trained BfN worker. The
Helpline has access to standard medical reference texts
(e.g. The British National Formulary [23]) and specialist
breastfeeding references, for example Hale's Medications
and Mother’s Milk [24], LactMed (an online database
from The National Library of Medicine) [25], Briggs et al's
Drugs in Pregnancy and Lactation [26] and Martindale
The Extra Pharmacopoeia [27].
Given the growth in user numbers, the aim of this study
was to assess consumer and healthcare professional opin-
ion, analyse the enquiries taken and to ascertain how in-
formation provided was used.
Methods
Enquirer opinion was surveyed via a structured telephone
interview or self-administered survey. A sample size calcu-
lator [28] indicated that 90 participants were required to
achieve 95% confidence (with a 10% margin for error) so
that the study results reflect the results expected from
the total enquirer population to the Helpline (in 2009,
n = 1388). Analysis of workload data and factoring in a
40% drop-out rate indicated that the study duration would
be approximately two months. Participant recruitment
began in December 2010.
Enquiries were generated either by telephone call or
email. All enquirers who contacted the service were eli-
gible to be enrolled in to the study, provided they were
English speakers. For telephone enquiries, prior to the BfN
call handler concluding the conversation, the enquirer was
informed of the study and asked if they would be happy tobe contacted in 2 to 4 weeks time to discuss the call fur-
ther. For those people who agreed to be contacted, their
details, along with the enquiry and answer provided by the
Helpline, were sent to researchers at the University of
Wolverhampton. Each caller was then telephoned and
interviewed. Interviews followed a semi-structured format
and took approximately 10 min to complete.
For email replies, information relating to the study was
included at the bottom of the written emailed reply, along
with an invitation to complete the self-administered sur-
vey. Return of the email was taken as the person giving
consent to participate. Questions used for both the inter-
views and surveys were drawn and adapted from UKMi
surveys used to quality assure their service.
Questions asked differed depending on whether the en-
quirer was a member of the public or a healthcare profes-
sional. However, the questions asked to each respective
group were the same for both the telephone interview and
self-administered survey. Data collected fell broadly into
three sections: demographic information; evaluation of
the Helpline; and usefulness of the information. Ques-
tions consisted of a mixture of open, closed and seman-
tic differential scales (e.g. 5 point Likert scales). Prior to
data collection starting, a two-week pilot study was
undertaken on the study population to determine the data
collection tools’ content validity and reliability. Feedback
from the pilot study showed that no changes were required.
Research ethics committee approval was granted by
The Behavioural Sciences Research Ethics Committee at
Wolverhampton University. NHS ethics approval was not
required as the work was assessed as evaluation and not
research.Data analysis
Responses were collated, stored and analysed using survey
software (SNAP for Windows) and spreadsheets (Microsoft
Excel 2003 for Windows). Data entry were performed by
two research assistants and the validity of data entry
assured by a member of the research team (PR) who was
not involved in data entry. PR undertook random checks of
the data (equating to approximately 20% of all data). Simple
descriptive statistics were used to summarise respondents’
data. Free text answers were reviewed and categorised by
PR. Data were managed using Excel and common themes
generated that were agreed upon by both authors.Results
One hundred and forty-two enquirers were contacted.
On follow up, twenty-one declined to participate and
twenty were lost, leaving 101 replies for analysis: 77 from
women (64 telephone calls and 13 emails); and 24 from
healthcare professionals (10 telephone calls and 14 emails).
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Demographic characteristics
Most women were under the age of forty (88%, n= 68/77),
had either 1 or 2 children (87%, n= 67/77), undertook for-
mal education beyond A levels (84%, n= 63/75) (i.e. fur-
ther education colleges or university) and were Caucasian
(92%, n= 70/76). No calls were received from any person
under the age of twenty-five. Demographic data are shown
in Table 1.Table 1 Characteristics of participants
Demographic characteristics of the breastfeeding women enquirers
n %




over 40 9 12






Ethnic origin (n = 76)
white 70 92
mixed 2 3
Asian/Asian British 3 4
other 1 1
School leaving age (n = 75)
16 or under 8 11
17 4 5
18 12 16
19 or over 51 68
Healthcare professional occupation (n = 24)
n %
Infant feeding co-ordinator 8 33




Community staff nurse 1 4
Community breastfeeding leader 1 4
Hospital nurse specialising in lactation 1 4
Not stated 1 4Breastfeeding women’s opinion on the helpline
Their experience with the service was very positive. Sev-
enty (91%) women were either ‘very satisfied’ or ‘satisfied’
with how quickly their call was answered and stated that
the answer they received provided sufficient information
to enable them to make a decision regarding their enquiry
(90%, n= 69/77). These findings are reflected in the level
of satisfaction noted, where 72 (94%) were either ‘very sat-
isfied’ or ‘satisfied’ with the overall service offered (Table 2).
Only three women felt that phoning the Helpline had not
helped them. Analysis of these three calls showed that two
involved complex calls, involving persistent nipple and
breast pain that were being managed unsatisfactorily by






n % n %
How did you find out about the telephone number?
Birth to Five 0 0 12 16
given it by someone 6 26 23 30
internet 8 35 27 35
leaflet 8 35 16 21
other 1 4 0 0
Have you called the Drugs in Breastmilk Helpline before?
Yes 17 71 13 17
No 7 30 64 83
Would you recommend this service to others?
Yes 22 92 77 100
No 2 9 0 0
Did the information provide you with enough information to
make a decision?
Completely 20 87 69 90
Partly 3 13 5 7
Not at all 0 0 3 4
How satisfied were you with the response to your query, with
respect to speed?
Very satisfied N/A N/A 64 83
Satisfied N/A N/A 6 8
Neither N/A N/A 5 7
Dissatisfied N/A N/A 2 3
Very dissatisfied N/A N/A 0 0
Overall, how satisfied were you with the service?
Very satisfied N/A N/A 69 90
Satisfied N/A N/A 3 4
Neither N/A N/A 4 5
Dissatisfied N/A N/A 1 1
Very dissatisfied N/A N/A 0 0
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that the woman could use the product, so it is unclear as
to why this person said the advice did not provide enough
information to make a decision.
Despite these enquirers not having been given infor-
mation to enable them to make a decision, they, as well
as all other women, said they would recommend the ser-
vice to other people (Table 2).
Most women (83%, n = 64) had not contacted the
Helpline before and found out about the service primar-
ily through the internet (35%, n = 27) or had been given
the telephone number (30%, n = 23). Twelve (16%) had
also been made aware by the ‘Birth to Five’ information
booklet (an NHS information booklet distributed to all
parents on the health, wellbeing and development of
children from birth to five years old) (Table 2).
Content of enquiries
Seventy enquiries directly related to medicine taking and
seven involved giving general advice (Table 3). Four of
the latter involved issues of infant feeding whilst the
mother was being treated with antifungal medication.
Sixty-five enquiries involved the use of proposed medi-
cines. These were predominantly to manage acute condi-
tions, with self-management of minor illness (n = 11),
anti-infectives (n=14) and pain relief (n=9) most fre-
quently enquired about. Seventeen enquiries involved medi-
cines that could be used for the management of long-term
illness. These covered many medicine classes, with only
medicines for depression (n=4) and Crohn’s disease (n=3)
receiving more than one enquiry.
Five calls involved medicines that were currently being
taken. Two concerned the effect medicines had on breast-
milk (amitriptyline and penicillin), whilst the other three
related to continuation of prescribed medication (asthma
inhalers, azathioprine and propylthiouracil). The latter three
enquirers had already spoken to a healthcare professional.
In the calls involving azathioprine and propylthiouracil the
women had been told by hospital physicians that they
should not take the medicine, but this advice had been con-
tradicted by pharmacists. In both instances the women
wanted clarification on what to do. The Helpline advisor
agreed with the pharmacist that the medicines could still be
taken whilst breastfeeding. The call involving asthma inha-






Healthcare professionals (n = 24) 13 (54%) 5 (
Breastfeeding women (n = 77)* 50 (65%) 17
* Two enquiries involved medicines for the treatment of proposed acute and chronadvice (to continue taking salbutamol and beclometasone
inhalers) given by a practice nurse was correct, which it was.
The Helpline stated that of the 70 enquiries involving
medicines, 68 could be taken whilst breastfeeding. All
women followed the guidance given by the Helpline. In
the two enquiries where the Helpline did not advise to
take the medicine, both involved referral back to the
physician on grounds of potential misdiagnosis.
Fifty-three women contacted a healthcare professional
before phoning the Helpline; 49 of these enquiries were
about the suitability of taking a medicine (Figure 1). Gen-
eral practitioners (n= 12) and hospital doctors (n= 8) were
most frequently asked for advice; other healthcare profes-
sionals were infrequently asked (pharmacists, n = 2; mid-
wife n= 2; health visitor n= 2; practice nurse n=1). In 10
instances women asked more than one healthcare profes-
sional for advice (in 7 cases two were asked, and in 3 cases
three were asked). The need for reassurance, and receiving
conflicting information were two common reasons why
women called the Helpline. Typical comments were:
‘Conflicting information between different sources, wasn't
sure which information was correct.’ (participant 70, tele-
phone interview)
‘Conflicting information between the physician, pharma-
cist and drug information.’ (participant 40, telephone
interview)
‘Instinctively I felt the drug would be fine, but just
wanted to double check.’ (participant 5, email survey)
‘I had to know whether such an extended period of not
breastfeeding was good for my baby. You were the only
group offering advice tailored to breastfeeding mums.’
(participant 9, email survey)
Women also often spoke of distrust of the advice given
by a healthcare professional or lack of confidence in their
answer:
‘Lack of confidence in the doctor’s advice as he sounded
confused and had to be reminded that I was breastfeeding.’
(participant 51, telephone interview)
‘Conflicting advice off the internet and didn't trust the
consultant’s advice.’ (participant 31, telephone interview)
‘Pharmacist wasn't sure; wanted to see if ok to use
while breastfeeding.’ (participant 33, telephone interview)
In 11 of the 49 enquiries, the healthcare professional
(seven of whom were physicians) was unsure of the answer







21%) 2 (8%) 4 (16%)
(22%) 5 (7%) 7 (9%)
ic illness.
49 breastfeeding women contacted a 
healthcare professional for advice on 
medicine taking 
11 HCPs unsure 
38 gave advice 
on medicine 
suitability 




10 told OK to 










HCPs said No 
Helpline said Yes 
In 1 case 
HCP said Yes 
Helpline said No 
In 10 cases 
HCPs gave conflicting 
information
Helpline said Yes 
Figure 1 Handling of medicine-related enquiries from breastfeeding women by healthcare professionals (HCPs) and the Drugs in
Breastmilk Helpline.
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from the Helpline, after consulting reference sources, were
able to advise the women that the medicine could be safely
taken. In the remaining enquiry, information was supplied
to the woman but no definitive answer on whether the
medicine could be taken was given. This enquiry was
answered by the BfN worker and, following protocol, is
only able to provide information and not advice on
whether the medication can be taken.
Just 17 of the remaining 38 enquiries saw agreement
between the healthcare professional and Helpline staff; in
all these enquiries both parties agreed that the medicine
could be taken.
In the 21 enquiries where there was disagreement,
healthcare professionals, on 10 occasions, said the medi-
cine should not be taken, but information from the
Helpline was that it was safe to take. In one enquiry the
healthcare professional stated the medicine could betaken, whereas Helpline staff recommended the mother
to speak again to the physician or a breastfeeding expert
about her symptoms, even though the medicine was safe
to use. In the remaining 10 enquiries women received
conflicting advice from two or more healthcare profes-
sionals; in all cases the Helpline staff advised that the
medicine could be taken.
For all enquiries where the healthcare professional was
either unsure or provided information contradictory to
the Helpline, women chose to follow the Helpline advice.
Table 4 highlights examples of the enquiries received
during the study.
Healthcare professional data
Enquiries were taken predominantly from people whose
role it is to support new mothers (Table 1). All (100%,
n = 24) healthcare professionals believed the Helpline re-
sponse either completely or partially answered their
Table 4 Examples of enquiries received and answers given
Enquiry Helpline response Resources used by Helpline
‘At around 37 weeks pregnant I had assumed that as
I had been told to continue my medication (antidepressant)
during pregnancy that it would be ok to breastfeed too, but I
raised the query with the registrar at my clinic just to double
check. He said he thought it would be fine but would check
in a book; he did this while I waited and then told me the book
said I should not breastfeed. He said he would check with the
hospital pharmacy and let me know. I received a letter
informing me it was ok for me to breastfeed whilst taking the
medication about 4 weeks after my baby was born. Luckily
enough I had contacted BfN rather than wait for the hospital to
let me know!!’
Information of studies carried out were supplied and an
explanation was given that it was important for the
patient to continue to take the medication so that she
remained well, and that the benefits of breastmilk to
her child far outweighed any risk to the baby through
her taking medication. The amount of drug passing to
the baby was discussed with the mother along with
any potential side effects to look out for.




‘Got a bad back and wanted to know if it was
safe to take naproxen or co-codamol (combination
paracetamol/codeine product). Both the doctor
and chemist said it was ok to take the medicines’.
The mother was provided with information from
Hale on the half lives of the drugs and how long
the drug would remain in the mother’s breastmilk.
Naproxen has a half life of 12–15 hours and the
amount passing into breastmilk is more than other
non steroidal anti-inflammatory drugs such as
ibuprofen or diclofenac. This makes it less preferable
if the baby is under 6 weeks of age before which
time hepatic and renal function is lower. There have
been concerns raised about the safety of co-codamol
during breastfeeding following the death of a baby in
Canada. The mother was counselled to watch for signs
of unusual drowsiness and poor feeding in the baby.
If she noticed these responses she was advised to stop
the drug and seek medical advice.







Have bleeding cracked nipples, slight inversion so
using nipple shields. Want something for pain and
also want to know what formula to use as concerned
about milk supply. Spoke with GP, pharmacist and
nurse but none gave a very clear answer.
Discussed moist wound healing and the need to
feed or express milk more frequently. Tried to
arrange a home visit from a breastfeeding
supporter to help with optimising attachment
of the baby at the breast, thereby preventing
further nipple trauma. Mother was contacted again
that evening; she was applying Vaseline to the cracks
to prevent scab formation and taking paracetamol.
She reported feeling better and will go back to
the breast support clinic the following week
Used information from:• BfN leaflet on moist wound healing
plus breastfeeding supportwww.breastfeedingnetwork.org.uk/
pdfs/Cracked_Nipples_and_Moist_Wound_Healing_2002.pdf
Patient called about general anaesthetic as she was
scheduled to have an ovarian cyst removed (planned
operation not emergency). Consultant said to stop
breastfeeding for 48 hours. Baby was 5 months old.
Mother was informed about short half life of drugs
used in general anaesthetic and that some of the drug
would remain in fat cells of the body, to be released
slowly over the following 48 hours, which might make
her baby drowsy. It was suggested that she breastfeed
as soon as she felt awake enough to do so. Information
on the effect of any anti-emetics, which might be given
was also discussed (could increase milk supply). Also
discussed how the mother would manage feeds
whilst in hospital, and whether she needed to have
a breast pump available.
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‘useful’ or ‘very useful’; consequently, the majority (92%,
n = 22/24) would recommend the service to others.
Table 2 shows that, in contrast to enquiries from breast-
feeding women, the majority (71%, n = 17/24) of health-
care professionals had used the Helpline previously and
preferred to email their enquiry (58%, n = 14/24 com-
pared to only 17%, n = 13/77 of women), even though
telephone responses were answered more quickly (100%
within 24 hours, compared to 79%). Like women, the
internet (35%, n = 8/23) and recommendation by another
person (26%, n = 6/23) were common ways that they
found out about the Helpline, although healthcare pro-
fessionals also stated leaflets (35%, n = 8/23) were fre-
quently the source of the information.
Analysis of the 24 enquiries showed that 18 were for pro-
posed medicines, 4 involved advice giving, and just 2 were
for medicines that were being currently taken (Table 3). Of
the 18 medicines for proposed use, 13 (72%) were to treat
acute problems. Medicines involved in these cases were
wide ranging, with only anti-infectives (n = 2) and domper-
idone (n= 2) occurring more than once. The 5 enquiries
received for proposed medicines to treat chronic condi-
tions were equally diverse, for example medicines to treat
schizophrenia, Attention Deficit Hyperactivity Disorder and
Cystic Fibrosis. The two enquiries that concerned medicines
being currently taken for chronic conditions were montelu-
kast for asthma and levothyroxine for hypothyroidism.
Fourteen (58%) had consulted at least one reference
source before contacting the Helpline. The most frequently
used reference text was Hale (a specialist text on the safety
of drugs in breastfeeding) (n =9) or the British National
Formulary (BNF - a standard text used in the UK for pre-
scribing information) (n= 6). In two cases, a hospital drug
information pharmacist was also consulted. Five of the six
people that consulted the BNF went on to say that the in-
formation it contained was not detailed enough to answer
the problem. One of these respondents also stated they did
not have access to Hale and thus called the Helpline. Hale
was most frequently consulted, yet despite it being more
informative than the BNF, 66% of respondents still con-
tacted the Helpline as they believed they would get a more
definitive answer based on prior use of the service. Where
healthcare staff contacted a specialist drug information
pharmacist, the information they provided was deemed in-
sufficient by the enquirer to answer their question.
Four of the 10 healthcare professionals stated that previ-
ous positive experiences of the Helpline prompted them to
contact the service rather than consult reference sources
and two called for reassurance (the other enquirers never
specified a reason).
All enquirers said the information provided by the Help-
line either completely (n= 20/23, 87%) or partly (n= 3/23,
13%) provided them with enough information to make adecision. Once in possession of the information, 22 went
on to say how they used the information. Thirteen passed
on the information to the patient, five gave the informa-
tion to the relevant prescriber and four used it to make a
treatment decision.
Discussion
The findings from this study show that the predomin-
ately pharmacist-led service provided by the BfN is well
received by both healthcare professionals and breast-
feeding women, and is consistent with user satisfaction
surveys of pharmacist-led drug information services [20,21].
Unlike most information services, the BfN Helpline actively
encourages the public to contact the service, and this was
reflected in a higher proportion of enquiries taken from the
public compared to healthcare professionals. Most women
were previous non-users of the service in contrast to
healthcare professionals, where the majority had contacted
the service before. The healthcare professionals predomin-
antly had a specialist role associated with maternal services
and this may explain why they were aware of the service.
Provision of the Helpline seems well-founded given
the level of conflicting information given by two or even
three healthcare staff, and the lack of confidence or dis-
trust women had in answers they provided. The dispar-
ity seen between the answers given by the Helpline and
the responses from healthcare staff further reinforces
the decision by their patients to seek out specialist ad-
vice. The fact that over 75% of healthcare staff did not
know the answer, or gave a conflicting answer compared
to that given by Helpline staff, suggests that healthcare
staff may not have sufficient knowledge or resources in
this field; which echoes previous findings [2-7,29,30].
Where Helpline staff contradicted healthcare staff advice,
breastfeeding women chose to follow Helpline advice. This
was not unexpected as many women had contacted the
Helpline as a ‘last resort’. However, in clinical practice the
contradiction of one healthcare professional by another
can be difficult, especially when one is perceived as more
authoritative than the other (e.g. lactation consultant doc-
tor versus a pharmacist). In these situations, it would seem
most prudent for the contradicting person to talk with the
person who gave the initial advice, so that a consistent
message is given to the breastfeeding women. This did not
routinely appear to happen in this study.
Findings from this study also raise questions about the
suitability of ‘generalist’ healthcare staff to handle breast-
feeding enquiries; in particular, physicians, as they were
most consulted. A study by Wallace and Kosmala-Anderson
reinforces this view, as they found that general practitioners
in the UK saw updates on prescribing for breastfeeding
mothers as a low priority, with just 19% highlighting this as
an area of need, despite only 34% describing themselves as
competent or expert in this field [31].
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consulted a reference source, and those that did found
standard texts, such as the BNF (which almost all UK
healthcare staff have easy access to), to be inadequate, as
data contained within it lacked sufficient detail. The de-
ficiency of the BNF has been highlighted by the National
Institute for Health and Clinical Excellence (NICE) and
advocates that healthcare professionals consult supple-
mentary sources of information [32]. Whilst some health-
care staff did consult other sources (i.e. the specialist text
by Hale), they still felt unsure on how to interpret the
information in a way that was useful to the mother, and
sought guidance from the Helpline. This lack of confi-
dence in interpretation of appropriate reference sources
suggests a greater need for training. It further supports
the use of a specialist, given their access to more
resources (as evidenced from Table 4) and ability to in-
terpret the data to provide informed answers on medi-
cine suitability.
A study by Akus also found that healthcare practitioners
were using outdated sources for making safety recommen-
dations to their patients [33]. Whilst this cannot be sub-
stantiated in this study, other studies [34] have found
similar results to Akus and it seems unlikely that health-
care staff in practice are using the most up-to-date refer-
ence sources when evaluating medicine suitability for
breastfeeding mothers.
Enquiries predominantly related to proposed medicines
to treat acute self-limiting problems. Advice given by
healthcare staff to patients erred on the side of caution; that
is they were told to avoid taking the medicine. Whilst this
negates any possible adverse events to the child, it does not
necessarily equate to appropriate clinical care where deci-
sions should be evidence-based and an assessment of the
risk versus benefits to the baby made [35,36]. In defence of
healthcare staff, the lack of manufacturer data on the
effects of medicines passing in to breastmilk makes recom-
mendation of products problematic. Without safety data,
manufacturers generally advocate avoidance. If products
are then recommended, prescribers do so outside of the
product licence, and liability will fall on that individual and
not the company. Amir and colleagues looked at know-
ledge, attitude and practices of Australian GPs in obtaining
information for medicines for breastfeeding women, and
found that medico-legal concerns were common, and 76%
stated that this was important in their decision-making
[37].
What is not in question is that patients will continue to
require medication during breastfeeding. Studies have
shown that this is relatively commonplace [38-40], and
medicines play an important part in a woman’s decision
to start and continue breastfeeding, with women fre-
quently hesitant to combine the two, choosing either to
stop breastfeeding or attempt to limit exposure [40-42].Therefore, given healthcare professional uncertainty and
caution in advice-giving, it was interesting to note that
the Helpline was able to give definitive answers in al-
most all cases relating to medicine taking. Given that
other countries do experience similar problems with
under-skilled healthcare staff in this field, then the es-
tablishment of similar Helplines could be considered.
The costs of running the BfN Helpline was initially
modest, but as call numbers have increased the Helpline
has had to rely on greater levels of goodwill from the
people that answer the enquiries. From our experience it
would be prudent, when starting such a Helpline, to fac-
tor in additional resources and money to meet increased
demand.
Limitations
It is acknowledged that this study provides a ‘snapshot’
of the service, and the number of participants was rela-
tively low. In addition, the study had a high drop-out
rate/lost to follow-up, which may have affected the data
through non-response bias. Lastly, the findings may not
be broadly generalisable to other countries due to differ-
ing healthcare structures.
Conclusion
The Breastfeeding Networks’ Drugs in Breastmilk Helpline
provides an important service to patients and healthcare
staff to make informed decisions on medicine-taking whilst
breastfeeding. The relatively high level of healthcare pro-
fessional uncertainty or incorrect advice given to patients,
coupled with patient distrust, signals that healthcare pro-
fessional education needs improving and that greater use
of specialist services should be encouraged.
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